Industry News

Versartis, Inc has completed enrollment of a Phase 3 study of somavaratan in pediatric patients with growth hormone deficiency. Somavaratan is a long-acting version of growth hormone created using Amunix's XTEN technology under license to Versartis. Somavaratan's twice-monthly dosing schedule in pediatric patients is the least frequent dosing interval in development for long-acting growth hormones."/>
Long Acting Growth Hormone Based on Amunix' XTEN(R) Technology Completes Enrollment of Phase 3 Trial
Obamacare Changes Leave Insurers Unmoved [The Hartford Courant]
JOHNSON CONTROLS POSTS CONSIDERATION ELECTION RESULTS IN TYCO MERGER US-based industrial company Johnson Controls has received preliminary results of the elections made by its shareholders as to the form of merger consideration they wish to receive in connection with Johnson Controls' merger with Irish fire and security firm Tyco, the company said on Wednesday. Based on the information as of the..."/>
M and A Navigator: Deal pipeline –1 September

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology685 Articles
Consumer Discretionary579 Articles
Financials446 Articles
Industrials380 Articles
Health Care379 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.